Modeling markers of disease progression by a hidden Markov process: application to characterizing CD4 cell decline.
about
Causal diagrams in systems epidemiologyFitting and interpreting continuous-time latent Markov models for panel dataHIV-1 disease progression during highly active antiretroviral therapy: an application using population-level data in British Columbia: 1996-2011.Joint estimation of CD4+ cell progression and survival in untreated individuals with HIV-1 infection.SEMIPARAMETRIC TIME TO EVENT MODELS IN THE PRESENCE OF ERROR-PRONE, SELF-REPORTED OUTCOMES-WITH APPLICATION TO THE WOMEN'S HEALTH INITIATIVEStudy design for non-recurring, time-to-event outcomes in the presence of error-prone diagnostic tests or self-reportsA coupled hidden Markov model for disease interactions.Using a nonparametric multilevel latent Markov model to evaluate diagnostics for trachoma.Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach.Adjusting for time-dependent sensitivity in an illness-death model, with application to mother-to-child transmission of HIV.Integrated study of copy number states and genotype calls using high-density SNP arrays.A state transition framework for patient-level modeling of engagement and retention in HIV care using longitudinal cohort data.Modeling nonhomogeneous Markov processes via time transformation.MCMC implementation for Bayesian hidden semi-Markov models with illustrative applications
P2860
Q30395155-8E205C15-9BE1-42F9-BB3D-85A89B3392B7Q30641833-5FC127DC-E96B-4E3B-BC13-F276DA9C9E61Q30679531-BFF7F706-C7E0-421E-9895-6695BFB9AEE3Q33631159-917D9586-AF09-40FF-80E3-59C4386BE0CAQ35911630-68C985F3-245D-48E2-B5A2-60CC7B1DC745Q36020433-2ECAFDFF-5522-44FF-9950-94681B804FC6Q37270087-B5F90590-51F5-422D-AB36-D2D1CB950EB7Q37846762-4CE5DF0D-7BAF-4042-841A-2761544F1DF0Q40060299-4C65AF4A-F0B5-42B4-A66A-D2E0ABD46266Q41578173-B80F1D8B-FC86-4478-933E-77F0B754544DQ41890841-0A20F344-FAEB-4EB6-B1D5-06D86C21F9F0Q46329396-0735FC92-90C0-42C5-A0D3-6238373738F7Q51899495-17C9A415-02DF-402F-BE16-F2760F54E28FQ57924047-0F228961-7E5C-45A6-BB8D-FA39AED2BE89
P2860
Modeling markers of disease progression by a hidden Markov process: application to characterizing CD4 cell decline.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Modeling markers of disease pr ...... aracterizing CD4 cell decline.
@en
Modeling markers of disease pr ...... aracterizing CD4 cell decline.
@nl
type
label
Modeling markers of disease pr ...... aracterizing CD4 cell decline.
@en
Modeling markers of disease pr ...... aracterizing CD4 cell decline.
@nl
prefLabel
Modeling markers of disease pr ...... aracterizing CD4 cell decline.
@en
Modeling markers of disease pr ...... aracterizing CD4 cell decline.
@nl
P2093
P2860
P1433
P1476
Modeling markers of disease pr ...... aracterizing CD4 cell decline.
@en
P2093
Guihenneuc-Jouyaux C
Longini IM Jr
Richardson S
P2860
P304
P356
10.1111/J.0006-341X.2000.00733.X
P407
P577
2000-09-01T00:00:00Z